Australia markets closed

LBX Pharmacy Chain Joint Stock Company (603883.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
18.36-0.84 (-4.38%)
At close: 03:00PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 13.96B
Enterprise value 17.02B
Trailing P/E 14.55
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.62
Price/book (mrq)1.98
Enterprise value/revenue 0.76
Enterprise value/EBITDA 10.36

Trading information

Stock price history

Beta (5Y monthly) 0.28
52-week change 3-20.25%
S&P500 52-week change 322.55%
52-week high 328.38
52-week low 317.55
50-day moving average 324.94
200-day moving average 322.90

Share statistics

Avg vol (3-month) 35.58M
Avg vol (10-day) 39.03M
Shares outstanding 5760.23M
Implied shares outstanding 6795.01M
Float 8362.07M
% held by insiders 153.20%
% held by institutions 117.01%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.38
Forward annual dividend yield 42.00%
Trailing annual dividend rate 30.51
Trailing annual dividend yield 32.65%
5-year average dividend yield 41.03
Payout ratio 430.49%
Dividend date 3N/A
Ex-dividend date 427 June 2024
Last split factor 21.3:1
Last split date 327 June 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 4.26%
Operating margin (ttm)8.81%

Management effectiveness

Return on assets (ttm)4.41%
Return on equity (ttm)15.38%

Income statement

Revenue (ttm)22.54B
Revenue per share (ttm)29.65
Quarterly revenue growth (yoy)1.80%
Gross profit (ttm)N/A
EBITDA 1.71B
Net income avi to common (ttm)958.95M
Diluted EPS (ttm)1.26
Quarterly earnings growth (yoy)10.30%

Balance sheet

Total cash (mrq)2.02B
Total cash per share (mrq)2.66
Total debt (mrq)5.09B
Total debt/equity (mrq)66.42%
Current ratio (mrq)0.89
Book value per share (mrq)9.25

Cash flow statement

Operating cash flow (ttm)2.3B
Levered free cash flow (ttm)-201.64M